NAT COMMUN:用视觉假体来恢复视力

2013-07-09 Nature Communications Nature Communication

本期Nature Communications上发表的一项研究表明,移植了视网膜假体的大鼠对光有视觉反应。当该假体被光刺激时,大鼠会在脑部负责视觉处理的区域诱发反应。 近年来,对有可能恢复盲人视力的光电池视觉假体的研究工作加快了步伐;与此同时,虽然它们已被发现能够刺激视网膜组织,但它们是否能恢复视力却没有被评估过。Yossi Mandel及其同事向视网膜退化的大鼠植入视觉假体,然后记录来自其脑中

本期Nature Communications上发表的一项研究表明,移植了视网膜假体的大鼠对光有视觉反应。当该假体被光刺激时,大鼠会在脑部负责视觉处理的区域诱发反应。

近年来,对有可能恢复盲人视力的光电池视觉假体的研究工作加快了步伐;与此同时,虽然它们已被发现能够刺激视网膜组织,但它们是否能恢复视力却没有被评估过。Yossi Mandel及其同事向视网膜退化的大鼠植入视觉假体,然后记录来自其脑中视皮层的神经反应,将这种反应作为视力恢复程度的一个度量。他们发现,视皮层反应可响应于光刺激被诱发。这里所用的光刺激与早先研究中所用的刺激相似,后者研究的是这些装置刺激视网膜组织的有效性。作者承认,还需要更多研究来确定这些装置在恢复全部视力上到底有多成功,但他们希望,这些研究将使人们对光电池方法用于视网膜假体的可行性更加有信心。

“色素性视网膜炎”和与年龄相关的黄斑部退化是西方两个最大的失明原因。虽然一些治疗方法对某些个体能延缓这些疾病的病情发展,但目前还没有已知的治愈手段。


Cortical responses elicited by photovoltaic subretinal prostheses exhibit similarities to visually evoked potentials

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1879562, encodeId=075f18e95626c, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Aug 24 23:12:00 CST 2013, time=2013-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086636, encodeId=5ee72086636ca, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Fri Nov 08 12:12:00 CST 2013, time=2013-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1743594, encodeId=5ccc1e43594f5, content=<a href='/topic/show?id=c92c42e3055' target=_blank style='color:#2F92EE;'>#复视#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42730, encryptionId=c92c42e3055, topicName=复视)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Tue Jan 07 01:12:00 CST 2014, time=2014-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1468287, encodeId=01d5146828e0a, content=<a href='/topic/show?id=2d3d2e5176a' target=_blank style='color:#2F92EE;'>#假体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27517, encryptionId=2d3d2e5176a, topicName=假体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b576903125, createdName=lanyan20020088, createdTime=Thu Jul 11 06:12:00 CST 2013, time=2013-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481045, encodeId=39371481045a4, content=<a href='/topic/show?id=c592908329c' target=_blank style='color:#2F92EE;'>#视觉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90832, encryptionId=c592908329c, topicName=视觉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Thu Jul 11 06:12:00 CST 2013, time=2013-07-11, status=1, ipAttribution=)]
    2013-08-24 liye789132251
  2. [GetPortalCommentsPageByObjectIdResponse(id=1879562, encodeId=075f18e95626c, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Aug 24 23:12:00 CST 2013, time=2013-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086636, encodeId=5ee72086636ca, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Fri Nov 08 12:12:00 CST 2013, time=2013-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1743594, encodeId=5ccc1e43594f5, content=<a href='/topic/show?id=c92c42e3055' target=_blank style='color:#2F92EE;'>#复视#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42730, encryptionId=c92c42e3055, topicName=复视)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Tue Jan 07 01:12:00 CST 2014, time=2014-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1468287, encodeId=01d5146828e0a, content=<a href='/topic/show?id=2d3d2e5176a' target=_blank style='color:#2F92EE;'>#假体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27517, encryptionId=2d3d2e5176a, topicName=假体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b576903125, createdName=lanyan20020088, createdTime=Thu Jul 11 06:12:00 CST 2013, time=2013-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481045, encodeId=39371481045a4, content=<a href='/topic/show?id=c592908329c' target=_blank style='color:#2F92EE;'>#视觉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90832, encryptionId=c592908329c, topicName=视觉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Thu Jul 11 06:12:00 CST 2013, time=2013-07-11, status=1, ipAttribution=)]
    2013-11-08 liuli5079
  3. [GetPortalCommentsPageByObjectIdResponse(id=1879562, encodeId=075f18e95626c, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Aug 24 23:12:00 CST 2013, time=2013-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086636, encodeId=5ee72086636ca, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Fri Nov 08 12:12:00 CST 2013, time=2013-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1743594, encodeId=5ccc1e43594f5, content=<a href='/topic/show?id=c92c42e3055' target=_blank style='color:#2F92EE;'>#复视#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42730, encryptionId=c92c42e3055, topicName=复视)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Tue Jan 07 01:12:00 CST 2014, time=2014-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1468287, encodeId=01d5146828e0a, content=<a href='/topic/show?id=2d3d2e5176a' target=_blank style='color:#2F92EE;'>#假体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27517, encryptionId=2d3d2e5176a, topicName=假体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b576903125, createdName=lanyan20020088, createdTime=Thu Jul 11 06:12:00 CST 2013, time=2013-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481045, encodeId=39371481045a4, content=<a href='/topic/show?id=c592908329c' target=_blank style='color:#2F92EE;'>#视觉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90832, encryptionId=c592908329c, topicName=视觉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Thu Jul 11 06:12:00 CST 2013, time=2013-07-11, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1879562, encodeId=075f18e95626c, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Aug 24 23:12:00 CST 2013, time=2013-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086636, encodeId=5ee72086636ca, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Fri Nov 08 12:12:00 CST 2013, time=2013-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1743594, encodeId=5ccc1e43594f5, content=<a href='/topic/show?id=c92c42e3055' target=_blank style='color:#2F92EE;'>#复视#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42730, encryptionId=c92c42e3055, topicName=复视)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Tue Jan 07 01:12:00 CST 2014, time=2014-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1468287, encodeId=01d5146828e0a, content=<a href='/topic/show?id=2d3d2e5176a' target=_blank style='color:#2F92EE;'>#假体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27517, encryptionId=2d3d2e5176a, topicName=假体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b576903125, createdName=lanyan20020088, createdTime=Thu Jul 11 06:12:00 CST 2013, time=2013-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481045, encodeId=39371481045a4, content=<a href='/topic/show?id=c592908329c' target=_blank style='color:#2F92EE;'>#视觉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90832, encryptionId=c592908329c, topicName=视觉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Thu Jul 11 06:12:00 CST 2013, time=2013-07-11, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1879562, encodeId=075f18e95626c, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Aug 24 23:12:00 CST 2013, time=2013-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086636, encodeId=5ee72086636ca, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Fri Nov 08 12:12:00 CST 2013, time=2013-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1743594, encodeId=5ccc1e43594f5, content=<a href='/topic/show?id=c92c42e3055' target=_blank style='color:#2F92EE;'>#复视#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42730, encryptionId=c92c42e3055, topicName=复视)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Tue Jan 07 01:12:00 CST 2014, time=2014-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1468287, encodeId=01d5146828e0a, content=<a href='/topic/show?id=2d3d2e5176a' target=_blank style='color:#2F92EE;'>#假体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27517, encryptionId=2d3d2e5176a, topicName=假体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b576903125, createdName=lanyan20020088, createdTime=Thu Jul 11 06:12:00 CST 2013, time=2013-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481045, encodeId=39371481045a4, content=<a href='/topic/show?id=c592908329c' target=_blank style='color:#2F92EE;'>#视觉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90832, encryptionId=c592908329c, topicName=视觉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Thu Jul 11 06:12:00 CST 2013, time=2013-07-11, status=1, ipAttribution=)]